KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).

Kenta Tane, Satoshi Shiono, Masashi Wakabayashi, Tomoko Kataoka, Noriko Mitome, Haruhiko Fukuda, Keiju Aokage, Shun-Ichi Watanabe, In behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group

Jpn J Clin Oncol 54(8) 926-929

PMID38693750
PMCID-
DOI10.1093/jjco/hyae056
发表日期2024-05-02
摘要

摘要

The goal of postoperative surveillance following non-small cell lung cancer surgery is to detect recurrence and second primary malignancies while curative treatment is still possible. Although several guidelines recommend that patients have computed tomography (CT) scans every 6 months for the first 2 years after resection, then once a year, there is no evidence that it is effective for survival, especially in locally advanced non-small cell lung cancer. In October 2022, we launched a multi-institutional, randomized controlled phase III trial for pathological stage II and IIIA non-small cell lung cancer patients to confirm the non-inferiority of less intensive surveillance with less frequent CT scans versus standard surveillance in terms of overall survival. The primary endpoint is overall survival. We intend to enroll 1100 patients from 45 institutions over 4 years. The trial has been registered in the Japan Registry of Clinical Trials under the code jRCT1030220361 (https://jrct.niph.go.jp/latest-detail/jRCT1030220361).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。